Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Timothy S. Huval is Chief Administrative Officer at Humana. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jan 3, 2025, each linked to the official Form 4.
Chief Administrative Officer
Disclosures on record
1
Companies involved
1
As of the latest filing on , Timothy S. Huval reported holding 7,111 shares of Humana (HUM), worth about $3.28M at the last close of $461 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Humana HUM | 7,111 | 7,111 direct | $461 | $3.28M | Dec 31, 2024 |
Is this Timothy S. Huval’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
HumanaHUM
Dec 31, 2024Sold~$949Kdisclosed Jan 3
DetailsOfficial recordTimothy S. Huval reported 0 open-market purchases and 21 sales here, 2017 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Timothy S. Huval has no open-market purchase on record since 2017. Sales in 8 of the 10 years since 2017.
Timothy S. Huval reported 0 open-market purchases and 21 sales since 2017; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $949K1×1 trade |
| 2023 | — | $1.34M1×1 trade |
| 2022 | — | $5.62M3×3 trades |
| 2021 | — | $3.11M2×2 trades |
| 2020 | — | $6.83M4×4 trades |
| 2019 | — | $4.95M3×3 trades |
| 2018 | — | $6.77M3×3 trades |
| 2017 | — | $10.7M4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Dec 31, 2024, Timothy S. Huval reported holding 7,111 shares of Humana (HUM). At the last close of $461 on Nov 16, 2026, that is about $3.28M. This is the stake disclosed in filings, not a net worth.
Timothy S. Huval has no open-market purchase on record since 2017. Sales in 8 of the 10 years since 2017.
In SEC filings since 2017: no open-market purchase is on record; the latest open-market sale is from 2024.
Humana (HUM), from 2017 to 2024: 0 purchases and 21 sales.